Back to Search
Start Over
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume
- Source :
- Blood; June 2024, Vol. 143 Issue: 24 p2464-2473, 10p
- Publication Year :
- 2024
-
Abstract
- •MTV affected outcomes of second-line treatment in both arms, and axi-cel improved EFS and PFS over standard care, irrespective of MTV.•Baseline MTV associated with grade ≥3 CRS and neurologic events after axi-cel treatment.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 143
- Issue :
- 24
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs65953109
- Full Text :
- https://doi.org/10.1182/blood.2023021620